Skip links

Prevent effects of iron overload in patients with hereditary haemochromatosis (HH) by early genetic testing and treatment initiation.

Hereditary haemochromatosis is one of the most prevalent genetic disorders in the Northern European population. It is characterized by progressive accumulation of iron in various organs. ViennaLab assays identify the most frequent genetic variants causing iron overload.

Haemochromatosis

  • Hereditary haemochromatosis (HH) is an inherited iron overload disorder characterized by excessive absorption and deposition of iron.
  • HH is caused by mutations in the HFETFR2 or FPN1 genes.
  • Over time, iron deposition can lead to dysfunction and failure in multiple organs.
  • If left untreated, HH can lead to liver cirrhosis, liver cancer, diabetes, arthritis, and cardiopathies.
  • The primary goal in the management of HH is to identify patients and initiate treatment before irreversible damage occurs.
  • Therefore, early diagnosis and treatment initiation are essential to allow a virtually normal life for affected individuals.

Link to ACG Clinical Guideline

Products

Name
REF
Unit Size
IFU
Brochure
Name
Haemochromatosis StripAssay® A
REF
4-220
Unit Size
20 tests
IFU
Brochure
Name
Haemochromatosis StripAssay® B
REF
4-210
Unit Size
20 tests
IFU
Brochure
Name
HFE C282Y RealFast™ Assay
REF
7-130
7-133
Unit Size
100 rxn
32 rxn
IFU
Brochure
Name
HFE H63D RealFast™ Assay
REF
7-140
7-143
Unit Size
100 rxn
32rxn
IFU
Brochure
Name
HFE mpx RealFast™ Assay
REF
7-135
7-138
Unit Size
100 rxn
32rxn
IFU
Brochure
View
Drag